301211SZSE

Implementation Announcement of 2025 Annual Profit Distribution

Hubei Biocause Heilen Pharmaceutical Co., Ltd.··4 pages

✨ AI Summary

Hubei Hendi Pharmaceutical Co., Ltd. announced the implementation of its 2025 annual profit distribution plan, approved by the shareholders' meeting on April 21, 2026. The company will distribute a cash dividend of RMB 0.6 per 10 shares, totaling RMB 25,056,000. The record date for the distribution is June 11, 2026, with the payment date set for June 12, 2026.

Summary generated by AI · Always verify with source document

Full Translation

AI Translation· azure_openai

Securities Code: 301211

Securities Abbreviation: Hendi Pharmaceutical

Announcement Number: 2026-026

Hubei Hendi Pharmaceutical Co., Ltd. (hereinafter referred to as "the Company") and all members of the Board of Directors guarantee that the content of this announcement is true, accurate, and complete, with no false records, misleading statements, or significant omissions.

The 2025 annual profit distribution plan of Hubei Hendi Pharmaceutical Co., Ltd. has been approved by the shareholders' meeting held on April 21, 2026. The details of the profit distribution are announced as follows:

Sign in to read the full translation

Free accounts get 10 full releases per month. Pro subscribers get unlimited access.

Sign in to read moreSee Pro pricing